Background: Pain is often one of the most debilitating symptoms in patients with advanced oncological disease. Patients with localized pain due to malignancy refractory to medical treatment can benefit from selective percutaneous cordotomy that disconnects the ascending pain fibers in the spinothalamic tract. Objectives: Over the past year, we have been performing percutaneous radiofrequency cordotomy with the use of the O-Arm intraoperative imaging system that allows both 2D fluoroscopy and 3D reconstructed computerized tomography imaging. We present our experience using this technique, focusing on technical nuances and complications. Methods: A retrospective analysis was conducted of all patients who underwent percutaneous cordotomy between March 2016 and March 2017. Results: Nineteen patients underwent percutaneous cordotomy procedures. Two patients developed intraoperative delirium and were unable to tolerate the procedure. In 16 out of 17 completed procedures, we achieved excellent immediate pain relief (94%). At 1 month after operation, 15 of the 17 (88%) patients were pain free, and at 3 months 5 out of 5 patients available for follow-up were still free of their original pain. Mirror pain developed in 6 of the 17 patients (35%), but was mild in 4 of these cases and controlled with medications. We experienced 1 serious complication (6%) of ipsilateral hemiparesis. Conclusion: Percutaneous cordotomy using the O-Arm is safe and effective in the treatment of intractable oncological pain.

1.
Vayne-Bossert P, Afsharimani B, Good P, Gray P, Hardy J: Interventional options for the management of refractory cancer pain - what is the evidence? Support Care Cancer 2016;24:1429-1438.
2.
Harsh V, Viswanathan A: Surgical/radiological interventions for cancer pain. Curr Pain Headache Rep 2013;17:331.
3.
Lordon SP: Interventional approach to cancer pain. Curr Pain Headache Rep 2002;6:202-206.
4.
Honey CR, Yeomans W, Isaacs A, Honey CM: The dying art of percutaneous cordotomy in Canada. J Palliat Med 2014;17:624-628.
5.
Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F, ESMO Guidelines Working Group: Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23(suppl 7):vii139-vii154.
6.
Kanpolat Y, Akyar S, Cağlar S, Unlü A, Bilgiç S: CT-guided percutaneous selective cordotomy. Acta Neurochir 1993;123:92-96.
7.
Raslan AM: Percutaneous computed tomography-guided radiofrequency ablation of upper spinal cord pain pathways for cancer-related pain. Neurosurgery 2008;62:226-234.
8.
Kanpolat Y, Ugur HC, Ayten M, Elhan AH: Computed tomography-guided percutaneous cordotomy for intractable pain in malignancy. Neurosurgery 2009;64:187-194.
9.
Bain E, Hugel H, Sharma M: Percutaneous cervical cordotomy for the management of pain from cancer: a prospective review of 45 cases. J Palliat Med 2013;16:901-907.
10.
Raslan AM, Cetas JS, McCartney S, Burchiel KJ: Destructive procedures for control of cancer pain: the case for cordotomy. J Neurosurg 2011;114:155-170.
11.
Collins KL, Patil PG: Flat-panel fluoroscopy O-arm-guided percutaneous radiofrequency cordotomy: a new technique for the treatment of unilateral cancer pain. Neurosurgery 2013;72:27-34.
12.
Zhang J, Weir V, Fajardo L, Lin J, Hsiung H, Ritenour ER: Dosimetric characterization of a cone-beam O-arm imaging system. J Xray Sci Technol 2009;17:305-317.
13.
Crul BJP, Blok LM, van Egmond J, van Dongen RTM: The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headache Pain 2005;6:24-29.
14.
France BD, Lewis RA, Sharma ML, Poolman M: Cordotomy in mesothelioma-related pain: a systematic review. BMJ Support Palliat Care 2014;4:19-29.
15.
Bellini M, Barbieri M: Percutaneous cervical cordotomy in cancer pain. Anaesthesiol Intensive Ther 2016;48:197-200.
16.
Nagaro T, Adachi N, Tabo E, Kimura S, Arai T, Dote K: New pain following cordotomy: clinical features, mechanisms, and clinical importance. J Neurosurg 2001;95:425-431.
17.
Higaki N, Yorozuya T, Nagaro T, Tsubota S, Fujii T, Fukunaga T, et al: Usefulness of cordotomy in patients with cancer who experience bilateral pain: implications of increased pain and new pain. Neurosurgery 2015;76:249-257.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.